Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Identify where to find high risk investments that offer potential for high returns. Explore various avenues to enhance your portfolio.
27,969 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
SpaceX is set to debut on the public market tomorrow after planning a record-breaking raise, drawing unprecedented in...
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
A Minnesota food vendor case highlights risks in federal child nutrition programs. Learn how the scheme worked, who’s...
Investors rushed to understand why intuitive surgical stock dropped this week. This article dissects the catalysts, g...
As Florida lawmakers race to finish a two-week session, a dispute over accessory dwelling unit rules could stall the ...
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
Investors once chased 30-day DSCR closings, hoping for a quick payday. Today, closings stretch beyond a month as unde...
Rising interest-rate expectations are shifting as traders weigh the impact of potential policy shifts. A Trump-led ea...
Virgin Galactic leads a broad rally in space stocks after a liquidity-boosting debt-for-equity swap. AST SpaceMobile,...
More than 40 analysts now rate AMD a Buy as AI-driven data center demand fuels growth. Here’s why the stock could pus...